Alexandria Real Estate Equities (ARE)
(Delayed Data from NYSE)
$116.24 USD
-0.87 (-0.74%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $116.23 -0.01 (-0.01%) 5:54 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$116.24 USD
-0.87 (-0.74%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $116.23 -0.01 (-0.01%) 5:54 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
Alexandria (ARE) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
While Alexandria's (ARE) Q3 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high-interest expenses and economic uncertainty raise concern.
Alexandria (ARE) Receives Rating Affirmation From Moody's
by Zacks Equity Research
Underpinning Alexandria's (ARE) solid operating and financial performance, Moody's Investors Service reaffirms the company's credit ratings of Baa1 and maintains its outlook rating at stable.
Alexandria (ARE) Expedites Delivery of Moderna's New HQ
by Zacks Equity Research
Alexandria (ARE) to hand over the new global headquarters and core R&D operations center to Moderna in November 2023. ARE will benefit from the project's incremental annual net operating income.
Will Rating Reaffirmation Boost Confidence in Alexandria (ARE)?
by Zacks Equity Research
The recent reaffirmation of Alexandria's (ARE) credit rating, with a positive outlook, underscores its financial strength and stability.
Here's Why You Should Retain Alexandria (ARE) Stock for Now
by Zacks Equity Research
The solid demand for high-quality life science and lab office properties in key markets and strategic buyouts bode well for Alexandria (ARE). However, a high interest rate is a key concern.
Welltower (WELL) Q2 FFO Tops, SHO Occupancy Up, '23 View Raised
by Zacks Equity Research
Welltower's (WELL) Q2 FFO outshines estimates on better-than-anticipated revenues, driven by robust SHO portfolio performance. It raises its 2023 normalized FFO per share outlook.
Digital Realty (DLR) Q2 FFO & Revenues Top, '23 View Revised
by Zacks Equity Research
Digital Realty's (DLR) Q2 earnings outshine estimates on higher revenues aided by solid rental revenue growth. The company revises its outlook for 2023.
Healthpeak's (PEAK) Q2 FFO & Revenues Beat, '23 View Revised
by Zacks Equity Research
Healthpeak's (PEAK) Q2 earnings outshine estimates on higher revenues. Same-store portfolio cash (adjusted) net operating income improves year over year. It revises its 2023 outlook.
American Tower (AMT) Q2 AFFO & Revenues Top, '23 View Revised
by Zacks Equity Research
American Tower's (AMT) Q2 results outshine estimates on higher revenues and strong organic tenant billing growth. It revises its outlook for 2023.
Alexandria's (ARE) FFO & Revenues Surpass Estimates in Q2
by Zacks Equity Research
Alexandria's (ARE) Q2 results outperform estimates on solid rental rate growth and healthy leasing activity. It narrows its 2023 adjusted FFO per share outlook.
Alexandria Real Estate Equities (ARE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Alexandria Real Estate Equities (ARE) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alexandria Real Estate Equities (ARE) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) delivered FFO and revenue surprises of 1.82% and 2.10%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
SL Green's (SLG) Q2 FFO Beats Estimates, Occupancy Falls
by Zacks Equity Research
While SL Green's (SLG) Q2 results reflect a decline in occupancy for its Manhattan same-store office portfolio, it witnesses decent growth in same-store cash net operating income.
Crown Castle (CCI) Q2 AFFO & Revenues Beat, '23 View Revised
by Zacks Equity Research
Crown Castle's (CCI) Q2 results outshine estimates on better-than-anticipated revenues. However, it lowered its outlook for 2023, expecting a decline in tower activity for the remainder of the year.
Alexandria (ARE) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Alexandria's (ARE) Q2 earnings are likely to have benefited from the solid demand for its high-quality life science and lab office properties and focus on internal and external growth efforts.
Prologis' (PLD) Q2 FFO Beats on Solid Rent Growth, '23 View Up
by Zacks Equity Research
Prologis' (PLD) second-quarter 2023 results reflect strong industrial real estate demand, leading to robust leasing activity and solid rent growth. It raises its core FFO per share outlook for 2023.
Here's Why You Should Retain Alexandria (ARE) Stock for Now
by Zacks Equity Research
The solid demand for high-quality life science and lab office properties in key markets and strategic buyouts bode well for Alexandria (ARE). However, a high interest rate is a key concern.
Alexandria (ARE) Recapitalizes San Diego Property at $981/RSF
by Zacks Equity Research
In sync with its capital-recycling strategy, Alexandria (ARE) and its JV partner divest 70% interest in 9625 Towne Centre Drive, fully leased to Takeda, in San Diego's UTC submarket at $981 per RSF.
Alexandria (ARE) Divests 5 Non-Core Properties for $365M
by Zacks Equity Research
Keeping up with its capital-recycling strategy, Alexandria (ARE) announces the disposition of five non-core assets in Greater Boston, spanning 428,663 rentable square feet, for $365 million.
Alexandria (ARE) Rewards Investors, Hikes Dividend by 2.5%
by Zacks Equity Research
Alexandria (ARE) boosts investors' confidence with a dividend hike of 2.5%. Robust operating results, a decent financial position and a lower payout ratio make the dividend rate sustainable.
Alexandria (ARE) Boosts Asset Recycling Strategy With $86M Sale
by Zacks Equity Research
Capitalizing on robust market valuations, Alexandria (ARE) propels its asset recycling strategy, selling a San Diego cluster property for $86 million.
Welltower (WELL) Q1 FFO Tops, SHO Occupancy Up, '23 View Raised
by Zacks Equity Research
Welltower's (WELL) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company raises its 2023 FFO per share outlook.
This is Why Alexandria Real Estate Equities (ARE) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Digital Realty (DLR) Q1 FFO Beats, Revenues Increase Y/Y
by Zacks Equity Research
Digital Realty's (DLR) Q1 performance reflects year-over-year growth in the top line. However, rising operating expenses act as a spoilsport.
Healthpeak's (PEAK) Q1 FFO Meets Estimates, Revenues Beat
by Zacks Equity Research
Healthpeak's (PEAK) Q1 performance reflects year-over-year growth in revenues. Same-store portfolio cash (adjusted) net operating income improves year over year.